Illumina Ventures
An independently managed venture firm with a strategic tie to the sequencing company Illumina. It backs genomics and precision health start-ups, including cancer companies such as Delfi Diagnostics, Actym Therapeutics and Oncko.
Overview
Illumina Ventures calls itself 'the premier genomics and precision health venture firm supporting early-stage companies to improve human health'. It is 'independently managed' with 'a strategic relationship with Illumina (NASDAQ: ILMN)', runs Illumina Ventures Labs to give genomics start-ups capital, sequencing and lab space, and is based at 500 Lincoln Centre Drive, Foster City, California, with a European office in Dublin. Its portfolio page lists oncology companies including Actym Therapeutics ('programmable, combination payload delivery to solid tumors'), Arima Genomics (3D genome structure applied to cancer), Delfi Diagnostics ('early cancer detection'), Oncko (multi-drug cancer combinations) and Serinus Biosciences ('redefining precision oncology'), alongside tools companies such as Alamar Biosciences.
Portfolio in OnCo (0)
Filter the startups tableNo OnCo company names this investor yet. Portfolio links are declared on the startup record (`investors`), so adding one there lists it here.
Notes
top- The task hint gave San Francisco; the contact page gives Foster City in the San Francisco Bay Area. Founding year not stated; omitted. Delfi Diagnostics and Iambic (a portfolio company) are already in the graph.